BP000134-GD21: Recombinant Human Interleukin-11 (IL-11) Protein
Source: P. Pichia-derived.
The ED50 as determined by the dose-dependant stimulation of the proliferation of murine 7TD1 was found to be less than 0.2 ng/ml, corresponding to a Specific Activity of 8.0 x 10^6 IU/mg.
Purity: > 95% by RP-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 EU/ug).BP000176-GD19: Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Protein
Source: E. coli-derived.
The ED50 as determined by the dose-dependant stimulation of the proliferation of human TF-1 cells (human erythroleukemic indicator cell line) is less then 0.1 ng/ml, corresponding to a Specific Activity of 1.0 x 10^7 IU/mg.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.01 ng/ug (0.1 IEU/ug).BP000145-GD20: Recombinant Human Interleukin-2 (IL-2) Protein
Source: E. coli-derived.
The ED50 as determined by the dose-dependant stimulation of murine CTLL-2 cells is less than 0.1 ng/ml, corresponding to a Specific Activity of 1.0 x 10^7 IU/ mg.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP000082-GD27: Recombinant Human IFN alpha 2a (IFNA2) Protein
Source: E. coli-derived.
The specific activity as determined by a viral resistance assay using VSV-WISH cells was found to be 1.0 x 10^8 IU/mg.
Purity: > 95% by RP-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 EU/ug).BP003060: Biotinylated Recombinant Human ACE2-His-Avi Protein (rhACE2-His)
Source: mammalian cells.
Activity: Immobilized recombinant SARS-CoV-2 (2019-nCoV) Spike S RBD at 1 ug/ml (100 ul/well). Dose response curve for the biotinylated recombinant human ACE2 protein with the EC50 of 0.1 ug/ml determined by ELISA.
Purity: > 95% by PAGE under reduced condition, and SEC-HPLC.BP003058: Biotinylated Recombinant SARS Spike RBD-His-Avi
Source: mammalian cells.
Purity: > 95% by PAGE under reduced condition, and SEC-HPLC.BP003059: Recombinant SARS Spike RBD-His-Avi
Source: mammalian cells.
Purity: > 95% by PAGE under reduced condition, and SEC-HPLC.BP000082-GD27: Recombinant Human IFN alpha 2a (IFNA2) Protein
Source: E. coli-derived.
The specific activity as determined by a viral resistance assay using VSV-WISH cells was found to be 1.0 x 10^8 IU/mg.
Purity: > 95% by RP-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 EU/ug).BP000094-CYT-137: Recombinant Human 4-1BB Receptor, His Tag
Source: E. coli-derived.
Purity: > 90% as determined by SDS-PAGE.BP000094-CYT-463: Recombinant Human 4-1BB Receptor
Source: E. coli-derived.
The activity was determined by the inhibition of 4-1BB ligand mediated stimulation of IL-8 production by human PBMC. Results: 90% inhibition using 1 for both 4-1BB ligand and 4-1BB receptor.
Purity > 98%, by SDS-PAGE and RP-HPLC.